Home › BLUESTARCO › Filing
🔔 Get instant alerts when BLUESTARCO files quarterly results on BSE Start free trial →
Blue Star Limited (BLUESTARCO)

Investor Presentation

Filed: 30 Oct 2026, 16:54 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2FY27 - Revenue ₹2,930.95 cr +21.0% y-y; EBITDA ₹202.58 cr; Net profit ₹123.91 cr +25.4% y-y - Electro-Mechanical Projects revenue up 16.3%, margin pressure due to material costs - Unitary Products revenue up 29.4%, margins down on partial cost pass-through - Professional Equipment revenue up 51.2%, margin improved on MedTech sale and warranty write-back - Carried-forward order book ₹7,229.22 cr +1.5% - H1FY27 revenue ₹6,308.87 cr +16.7%, net profit ₹226.42 cr +3.1% - Net borrowings ₹706 cr; net debt-equity improved to -0.08 - ESG focus on energy efficiency, diversity, and governance excellence
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 BLUESTARCO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add BLUESTARCO to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Blue Star Limited

Important. The summary above is generated automatically from Blue Star Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.